Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02937584” into
the search box and click “Search”.
• www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2015-001744-11” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“PT003019” into the search box, and click “Find a Study”.
Full study title: A Randomized, Double-Blind, Two Treatment, Two Period,
Chronic Dosing (2 Weeks), Cross-Over, Multi-Center Study to Evaluate the Effects
of PT001 and PT005 on Specific Image Based Airway Volumes and Resistance in
Subjects With Moderate to Severe COPD.
AstraZeneca protocol number: PT003019
Pearl Therapeutics, Inc., a member of the AstraZeneca Group, sponsored this
study and has its headquarters at
Pearl Therapeutics, Inc. 200 Cardinal Way, 2nd Floor Redwood City, CA 94063
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical
Research Participation (CISCRP) is a non-profit
organization focused on educating and informing the
public about clinical research participation. CISCRP is
not involved in recruiting patients for clinical studies, nor
is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100
Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
V4.0 2019_05_06